Internal Medicine, Hematology & Oncology · Anchorage, AK
NPI
1952528499
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
3851 Piper St. U340
Anchorage, AK, 99508
Phone (907) 562-0321
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
106,050 services
Medicare patients, 2024
474
Average age 73
Drug cost, 2024
$1.3M
679 prescriptions
Company payments, 2025
$429
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ellen H Chirichella was code J9271 (injection, pembrolizumab, 1 mg), 11,600 times for 12 patients. In total Ellen H Chirichella billed 106,050 services in 127 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 11,600 | 12 | $44.70 | $519K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 8,850 | 25 | $0.11 | $968 |
| J0897 Injection, denosumab, 1 mg | Office | 6,300 | 24 | $20.11 | $127K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,187 | 13 | $0.08 | $429 |
| J9312 Injection, rituximab, 10 mg | Office | 1,680 | 12 | $61.50 | $103K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,476 | 47 | $0.09 | $132 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 900 | 32 | $0.79 | $709 |
| 85025 Blood Count | Office | 754 | 298 | $7.58 | $5,712 |
| 80053 Clinical Chemistry | Office | 728 | 296 | $10.30 | $7,499 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 511 | 15 | $3.70 | $1,893 |
| 99214 Office E&M - Established | Office | 500 | 241 | $128.29 | $64K |
| 99213 Office E&M - Established | Office | 348 | 215 | $83.81 | $29K |
| J9190 Injection, fluorouracil, 500 mg | Office | 346 | 15 | $2.34 | $809 |
| 96375 Injection Administration | Office | 326 | 54 | $14.77 | $4,816 |
| J9045 Injection, carboplatin, 50 mg | Office | 326 | 13 | $2.79 | $909 |
By year: 2022 $1.4M for 86,185 services; 2023 $1.9M for 114,071 services; 2024 $2.2M for 106,050 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 754 | 298 | $7.58 | $5,712 |
| 80053 Clinical Chemistry | 728 | 296 | $10.30 | $7,499 |
| 83615 Clinical Chemistry | 80 | 47 | $5.92 | $474 |
| 83735 Clinical Chemistry | 70 | 32 | $6.48 | $453 |
Medicare prescription drug claims, 2024
In 2024, the drug Ellen H Chirichella prescribed most often to Medicare patients was Anastrozole, with 201 prescriptions and refills. In total Ellen H Chirichella wrote 679 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 201 | 532 | 67 | $9,924 |
| Exemestane Generic | 85 | 157 | 21 | $16K |
| Alendronate Sodium Generic | 38 | 60 | Under 11 | $247 |
| Calquence Acalabrutinib Maleate | 30 | 30 | Under 11 | $451K |
| Letrozole Generic | 25 | 73 | Under 11 | $1,046 |
| Pantoprazole Sodium Generic | 20 | 28 | Under 11 | $199 |
| Xarelto Rivaroxaban | 16 | 22 | Under 11 | $12K |
| Gabapentin Generic | 16 | 24 | Under 11 | $309 |
| Tamoxifen Citrate Generic | 16 | 41 | Under 11 | $748 |
| Arimidex Anastrozole | 14 | 18 | Under 11 | $28K |
| Tagrisso Osimertinib Mesylate | 12 | 12 | Under 11 | $213K |
Brand drugs: 134 claims; generic drugs: 545 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ellen H Chirichella $429 ($429 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novartis Pharmaceuticals Corporation with $122.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 5 | $122 |
| Pfizer Inc. PFE | 3 | $63.17 |
| Abbvie Inc. ABBV | 2 | $62.63 |
| Astellas Pharma US Inc 4503.T | 1 | $30.26 |
| SpringWorks Therapeutics, Inc. | 1 | $26.32 |
| Gilead Sciences, Inc. GILD | 1 | $23.91 |
| BeOne Medicines USA, Inc. ONC | 1 | $23.64 |
| Array Biopharma Inc PFE | 1 | $21.25 |
| Incyte Corporation INCY | 1 | $20.69 |
| Cycle Pharmaceuticals Inc | 1 | $19.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.